Send feedback

PTCH2 p.Pro852fs

c.2553dup · rs748351060 · VCV2151579

Uncertain significance Single submitter
Classification
Uncertain significance
ClinVar
Review
Single submitter ★☆☆☆
ClinVar · 1 submitter
Consequence
frameshift
predicted LoF
gnomAD v4.1
Rare
very rare (popmax 0.00534%, nfe)
Conditions
1
nevoid basal cell carcinoma syndrome

Computational evidence

Protein change
Missense predictors do not apply to this variant type; conservation carries the signal.
Consequenceframeshiftpredicted loss-of-function
NMDpredictedpremature termination codon in exon 17 of 22
Splicing
SpliceAI—not assessed · substitutions only
Constraint at this position
ConservationphyloP 6.5GERP -0.44, phastCons 1
Overall
CADD32.0PHRED · no single calibrated threshold — expert panels disagree

Predicted loss-of-function is descriptive, not an applied PVS1 code.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.00534% European (non-Finnish) · 63/1,180,030 alleles
Filtering AF 0.00426% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.00387%
Overall 0.00514% 83/1,613,990 alleles · very rare exomes 81/1,461,796 · genomes 2/152,194 · joint denominator
Ancestry group Frequency 1 in
Remaining individualsnot grpmax-eligible 0.024% 4,166
Finnishnot grpmax-eligible 0.00782% 12,792
European (non-Finnish)grpmax 0.00534% 18,731

Remaining individuals shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
PTCH2
Protein
p.Pro852fs
Coding
c.2553dup
MANE Select
NM_003738
dbSNP
rs748351060
Type
Duplication
Location
chr1:44827043 (GRCh38)
Gene constraint
LOEUF 0.895 · pLI <0.01 (gnomAD)
Structure
AlphaFold pLDDT 79.25
Residue 852
the 'extracellular domain 2 (ecd2)' region
Full PTCH2 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/ptch2-p-pro852fs (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown